<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7833385\results\search\disease\results.xml">
  <result pre="severe cases of COVID-19, many patients with mild disease without" exact="pneumonia" post="or moderate disease with pneumonia have received different classes"/>
  <result pre="patients with mild disease without pneumonia or moderate disease with" exact="pneumonia" post="have received different classes of antibiotics. Diarylureas are tyrosine"/>
  <result pre="the last twenty years, humans have encountered five pandemic diseases," exact="severe acute respiratory syndrome" post="(SARS), Avian flu, Ebola, Middle East respiratory syndrome (MERS)"/>
  <result pre="characterized by acute lung and liver failure, acute kidney injury," exact="cardiovascular disease," post="and a wide spectrum of hematological abnormalities and neurological"/>
  <result pre="biological activities [16,17]. Indeed, they are antimicrobials, particularly active in" exact="schistosomiasis" post="and malaria [18,19,20], anti-inflammatory, antiplatelet, and antiviral agents [21,22],"/>
  <result pre="[16,17]. Indeed, they are antimicrobials, particularly active in schistosomiasis and" exact="malaria" post="[18,19,20], anti-inflammatory, antiplatelet, and antiviral agents [21,22], and allosteric"/>
  <result pre="of this disease. It is known that the novel coronavirus" exact="pneumonia" post="is closely associated with inflammatory storms. Indeed, the patients"/>
  <result pre="responses and comorbid conditions, such as hypertension and type 2" exact="diabetes mellitus," post="may substantially raise the respiratory syndrome coronavirus 2 (SARS-CoV-2)"/>
  <result pre="mansoni [42]. S. japonicum is responsible for intestinal and hepatosplenic" exact="schistosomiasis" post="in China, the Philippines, and Indonesia; S. haematobium determines"/>
  <result pre="in China, the Philippines, and Indonesia; S. haematobium determines urogenital" exact="schistosomiasis" post="in Africa and in some countries of the Arabian"/>
  <result pre="1970s, is the only drug available for the treatment of" exact="schistosomiasis" post="[44]; no schistosomiasis vaccines have been accepted for public"/>
  <result pre="only drug available for the treatment of schistosomiasis [44]; no" exact="schistosomiasis" post="vaccines have been accepted for public use yet [45]."/>
  <result pre="screens of pharmaceutical and academic libraries against the Plasmodium falciparum" exact="malaria" post="parasite [46]. The antischistosomal properties of some of these"/>
  <result pre="growth factor I receptor (IGF-1R) signaling and then studied in" exact="breast cancer" post="and osteosarcoma [15]. Recently, it has been proposed as"/>
  <result pre="factor I receptor (IGF-1R) signaling and then studied in breast" exact="cancer" post="and osteosarcoma [15]. Recently, it has been proposed as"/>
  <result pre="receptor (IGF-1R) signaling and then studied in breast cancer and" exact="osteosarcoma" post="[15]. Recently, it has been proposed as a lead"/>
  <result pre="especially because of the emergence of resistance strain of Mycobacterium" exact="tuberculosis" post="against antibiotics. Compounds 20 and 21 inhibited M. tuberculosis"/>
  <result pre="Mycobacterium tuberculosis against antibiotics. Compounds 20 and 21 inhibited M." exact="tuberculosis" post="H37Rv up to 98% and 94%, respectively, at a"/>
  <result pre="MIC values of 6.0 and 5.2 Âµg/mL, respectively, against M." exact="tuberculosis" post="pathogenic strain H37Rv and 2.0 and 1.0, respectively, against"/>
  <result pre="pathogenic strain H37Rv and 2.0 and 1.0, respectively, against M." exact="tuberculosis" post="nonpathogenic strain mc26030. They also showed selective inhibition of"/>
  <result pre="by using a viral plaque-forming assay and the A549 human" exact="lung carcinoma" post="cell line, described as highly permissive to Zika infection"/>
  <result pre="might serve as useful agents in the treatment of asthma," exact="rheumatoid arthritis," post="inflammatory bowel disease, multiple sclerosis, Alzheimerâ€™s disease (AD), and"/>
  <result pre="in the treatment of asthma, rheumatoid arthritis, inflammatory bowel disease," exact="multiple sclerosis," post="Alzheimerâ€™s disease (AD), and stroke [82]. In interstitial pneumonia"/>
  <result pre="arthritis, inflammatory bowel disease, multiple sclerosis, Alzheimerâ€™s disease (AD), and" exact="stroke" post="[82]. In interstitial pneumonia (IP), integrin Î±4Î²1 expression level"/>
  <result pre="multiple sclerosis, Alzheimerâ€™s disease (AD), and stroke [82]. In interstitial" exact="pneumonia" post="(IP), integrin Î±4Î²1 expression level is known to be"/>
  <result pre="major cause of death of COVID-19 patients is characterized by" exact="respiratory failure" post="due to IP [84]. Compounds 37 and 38 (Table"/>
  <result pre="anti-inflammatory drugs and so on). As most of the early-detected" exact="bacterial pneumonia" post="can be safely and effectively treated with antibiotics, the"/>
  <result pre="drugs and so on). As most of the early-detected bacterial" exact="pneumonia" post="can be safely and effectively treated with antibiotics, the"/>
  <result pre="insulin like growth factor I receptor IL-6 interleukin-6 IP interstitial" exact="pneumonia" post="KB binding affinity LPS lipopolysaccharide MenG demethylmenaquinone methyltranferase MERS"/>
  <result pre="regulator PA platelet aggregation PD Parkinsonâ€™s disease PZQ praziquantel SARS" exact="severe acute respiratory syndrome" post="SARS-CoV respiratory syndrome coronavirus SARS-CoV-2 respiratory syndrome coronavirus 2"/>
  <result pre="soluble epoxide hydrolase Sps bacterial signal peptidase I enzyme TB" exact="tuberculosis" post="TCC triclocarban TRPV1 transient receptor potential vanilloid 1 TST"/>
  <result pre="of an open-label non-randomized clinical trialInt. J. Antimicrob. Agents20205610594910.1016/j.ijantimicag.2020.10594932205204 12.GinsburgA.S.KlugmanK.P.COVID-19" exact="pneumonia" post="and the appropriate use of antibioticsLancet Glob. Health20208e1453e145410.1016/S2214-109X(20)30444-733188730 13.FarhaM.A.BrownE.D.Drug"/>
  <result pre="Dis.201711e000542410.1371/journal.pntd.000542428771480 42.CampbellC.H.Jr.BinderS.KingC.H.KnoppS.RollinsonD.PersonB.WebsterB.AllanF.UtzingerJ.AmeS.M.et al.SCORE operational research on moving toward interruption of" exact="schistosomiasis" post="transmissionAm. J. Trop. Med. Hyg.2020103Suppl. 1586510.4269/ajtmh.19-082532400354 43.McManusD.P.BergquistR.CaiP.RanasingheS.TebejeB.M.YouH.Schistosomiasis-from immunopathology to"/>
  <result pre="= 2â€’4 Âµg/mL(various MRSA) [68] 20 MIC = 6.25 Âµg/mL(M." exact="tuberculosis" post="H37Rv) [69] 21 MIC = 3.125 Âµg/mL(M. tuberculosis H37Rv)"/>
  <result pre="6.25 Âµg/mL(M. tuberculosis H37Rv) [69] 21 MIC = 3.125 Âµg/mL(M." exact="tuberculosis" post="H37Rv) [69] 22 MIC = 6.0 Âµg/mL (M. tuberculosis"/>
  <result pre="Âµg/mL(M. tuberculosis H37Rv) [69] 22 MIC = 6.0 Âµg/mL (M." exact="tuberculosis" post="pathogenic strain H37Rv)MIC = 2.0 Âµg/mL (M. tuberculosis nonpathogenic"/>
  <result pre="Âµg/mL (M. tuberculosis pathogenic strain H37Rv)MIC = 2.0 Âµg/mL (M." exact="tuberculosis" post="nonpathogenic strain mc26030) [70] 23 MIC = 5.2 Âµg/mL"/>
  <result pre="nonpathogenic strain mc26030) [70] 23 MIC = 5.2 Âµg/mL (M." exact="tuberculosis" post="pathogenic strain H37Rv)MIC = 1.0 Âµg/mL (M. tuberculosis nonpathogenic"/>
  <result pre="Âµg/mL (M. tuberculosis pathogenic strain H37Rv)MIC = 1.0 Âµg/mL (M." exact="tuberculosis" post="nonpathogenic strain mc26030) [70] Antifungal activity 24 Inhibition, at"/>
  <result pre="IC50 = 160.3 nM(by viral plaque assay and A549 human" exact="lung carcinoma" post="cell line) [73] ASN 07115873 IC50 = 189.2 pM(by"/>
  <result pre="IC50 = 189.2 pM(by viral plaque assay and A549 human" exact="lung carcinoma" post="cell line) [73] ASN 07115881 IC50 = 317.7 pM(by"/>
  <result pre="IC50 = 317.7 pM(by viral plaque assay and A549 human" exact="lung carcinoma" post="cell line) [73] ASN 07115927 IC50 = 26.9 nM(by"/>
  <result pre="IC50 = 26.9 nM(by viral plaque assay and A549 human" exact="lung carcinoma" post="cell line) [73] 25 IC50 = 85.1 pM(by viral"/>
  <result pre="IC50 = 85.1 pM(by viral plaque assay and A549 human" exact="lung carcinoma" post="cell line) [74] DENV 26 IC50 = 91 ÂµM(DENV"/>
 </snippets>
</snippetsTree>
